Pindolol augmentation of antidepressant response

Current Drug Targets

Volumn 7, Issue 2, 2006, Pages 139-147

  Artigas, Francesc ^a   Adell, Albert ^a   Celada, Pau ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

adrenoceptors; 5 HT1A receptor; Antagonist; Antidepressant; Depression; Onset of action; Pindolol; Serotonin; SSRI

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PINDOLOL; PLACEBO; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; SEROTONIN ANTAGONIST;

ADD ON THERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG TARGETING; ELECTROCONVULSIVE THERAPY; ENZYME INHIBITION; HUMAN; MAJOR DEPRESSION; META ANALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVIEW; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; SLEEP DEPRIVATION; SYSTEMATIC REVIEW; THERAPY RESISTANCE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; TREATMENT OUTCOME;

BRAIN; DEPRESSION; HUMANS; PINDOLOL; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 33644854626     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006775515446     Document Type: Review

References (87)

1. Angst, J. (1992) Psychopharmacology (Berl.), 106, S71-S74.
2. Lepine, J.P.; Gastpar, M.; Mendlewicz, J. and Tylee, A. (1997) Int. Clin. Psychopharmacol., 12, 19-29.
3. Murray, C.J.L. and Lopez, A.D. (1997) Lancet, 349, 1498-1504.
4. Danish University Antidepressant Group (1990) J. Affect. Disord., 19, 289-299.
5. Danish University Antidepressant Group (1986) Psychopharmacology, 90, 131-138.
6. Artigas, F. (1995) CNS Drugs, 4, 79-89.
7. Nutt, D.J. (2002) Int. Clin. Psychopharmacol., 17(Suppl. 1), S1-12.
8. Tollefson, G.D. and Holman, S.L. (1994) Int. Clim Psychopharmacol., 9, 245-250.
9. Bech, P.; Cialdella, P.; Haugh, M.C.; Birkett, M.A.; Hours, A.; Boissel, J.P. and Tollefson, G.D. (2000) Brit. J. Psychiat., 176, 421-428.
10. Cornwall, P.L. and Scott, J. (1997) Acta Psychiatr. Scand., 95, 265-271.
11. Bschor, T.; Lewitzka, U.; Sasse, J.; Adli, M.; Koberle, U. and Bauer, M. (2003) Pharmacopsychiatry, 36(Suppl. 3), 230-234.
12. Jacobs, B.L. and Azmitia, E.C. (1992) Physiol Rev., 72, 165-229.
13. Barnes, N.M. and Sharp, T. (1999) Neuropharmacology, 38, 1083-1152.
14. Adell, A.; Celada, P.; Abellan, M.T. and Artigas, F. (2002) Brain Res. Rev., 39, 154-180.
15. Oleskevich, S. and Descarries, L. (1990) Neuroscience, 34, 19-33.
16. Beaudet, A. and Descarries, L. (1978) Neuroscience, 3, 851-860.
17. Sprouse, J.S. and Aghajanian, G.K. (1986) Eur. J. Pharmacol., 128, 295-298.
18. Blier, P. and de Montigny, C. (1987) Synapse, 1, 470-480.
19. Adell, A. and Artigas, F. (1991) Naunyn-Schmied. Arch. Pharmacol., 343, 237-244.
20. Artigas, F.; Romero, L.; de Montigny, C. and Blier, P. (1996) Trends Neurosci., 19, 378-383.
21. Casanovas, J.M.; Lesourd, M. and Artigas, F. (1997) Br. J. Pharmacol., 122, 733-741.
22. Adell, A.; Celada, P. and Artigas, F. (2001) J. Neurochem., 79, 172-182.
23. De Felipe, J.; Arellano, J.I.; Gomez, A.; Azmitia, E.C. and Muñoz, A. (2001) J. Comp. Neurol., 433, 148-155.
24. Czyrak, A.; Czepiel, K.; Mackowiak, M.; Chocyk, A. and Wedzony, K. (2003) Brain Res., 989, 42-51.
25. Araneda, R. and Andrade, R. (1991) Neuroscience, 40, 399-412.
26. Amargós-Bosch, M.; Bortolozzi, A.; Puig, M.V.; Serrats, J.; Adell, A.; Celada, P.; Toth, M.; Mengod, G. and Artigas, F. (2004) Cereb. Cortex, 14, 281-299.
27. Sprouse, J.S. and Aghajanian, G.K. (1987) Synapse, 1, 3-9.
28. Tanaka, E. and North, R.A. (1993) J. Neurophysiol., 69, 1749-1757.
29. Ashby, C.R.; Edwards, E. and Wang, R.Y. (1994) Synapse, 17, 173-181.
30. Celada, P.; Puig, M.V.; Casanovas, J.M.; Guillazo, G. and Artigas, F. (2001) J. Neurosci., 21, 9917-9929.
31. Cortés, R.; Soriano, E.; Pazos, A.; Probst, A. and Palacios, J.M. (1988) Neuroscience, 27, 473-496.
32. Saura, J.; Kettler, R.; Prada, M.D. and Richards, J.G. (1992) J. Neurosci., 12, 1977-1999.
33. Bel, N. and Artigas, F. (1992) Eur. J. Pharmacol., 229, 101-103.
34. Celada, P. and Artigas, F. (1993) Naunyn-Schmied. Arch. Pharmacol., 347, 583-590.
35. Blier, P. and de Montigny, C. (1994) Trends Pharmacol. Sci., 15, 220-226.
36. Rollema, H.; Clarke, T.; Sprouse, J.S. and Schulz, D.W. (1996) J. Neurochem., 67, 2204-2207.
37. Hervás, I.; Queiroz, C.M.; Adell, A. and Artigas, F. (2000) Br. J. Pharmacol., 130, 160-166.
38. Bel, N. and Artigas, F. (1993) Synapse, 15, 243-245.
39. Svensson, T.H.; Bunney, B.S. and Aghajanian, G.K. (1975) Brain Res., 92, 291-306.
40. Invernizzi, R.W.; Parini, S.; Sacchetti, G.; Fracasso, C.; Caccia, S.; Annoni, K. and Samanin, R. (2001) Br. J. Pharmacol., 132, 183-188.
41. Mateo, Y.; Fernandez-Pastor, B. and Means, J.J. (2001) Br. J. Pharmacol., 133, 1362-1370.
42. Artigas, F. (1993) Trends Pharmacol. Sci., 14, 262.
43. Knobelman, D.A.; Hen, R. and Lucki, I. (2001) J Pharmacol. Exp. Ther., 298, 1083-1091.
44. Bortolozzi, A.; Amargós-Bosch, M.; Toth, M.; Artigas, F. and Adell, A. (2004) J. Neurochem., 88, 1373-1379.
45. Artigas, F.; Pérez, V. and Alvarez, E. (1994) Arch. Gen. Psychiatry, 51, 248-251.
46. Romero, L.; Bel, N.; Artigas, F.; de Montigny, C. and Blier, P. (1996) Neuropsychopharmacology, 15, 349-360.
47. Blier, P. and Bergeron, R. (1995) J. Clin. Psychopharmacol., 15, 217-222.
48. Artigas, F.; Celada, P.; Laruelle, M. and Adell, A. (2001) Trends Pharmacol. Sci., 22, 224-228.
49. Ballesteros, J. and Callado, L.F. (2004) J. Affect. Disord., 79, 137-147.
50. Sokolski, K.N.; Cooney, J.C.; Brown, B.J. and Demet, E.M. (2004) Psychiatry Res., 125, 81-86.
51. Zanardi, R.; Artigas, F.; Franchini, L.; Sforzini, L.; Gasperini, M.; Smeraldi, E. and Pérez, J. (1997) J. Clin. Psychopharmacol., 17, 446-450.
52. Pérez, V.; Gilaberte, I.; Faries, D.; Alvarez, E. and Artigas, F. (1997) Lancet, 349, 1594-1597.
53. Isaac, M.T.; Isaac, M.B.; Gallo, F. and Tournoux, A. (2003) Hum. Psychopharmacol., 18, 595-601.
54. Zanardi, R.; Serretti, A.; Rossini, D.; Franchini, L.; Cusin, C.; Lattuada, E.; Dotoli, D. and Smeraldi, E. (2001) Biol. Psychiatry, 50, 323-330.
55. Rasanen, P.; Hakko, H.; Jokelainen, J. and Tiihonen, J. (1999) J. Affect. Disord., 55, 67-71.
56. Pérez, V.; Puigdemont, D.; Gilaberte, I.; Alvarez, E. and Artigas, F. (2001) J. Clin. Psychopharmacol., 21, 36-45.
57. Raurich, A.; Mengod, G.; Artigas, F. and Cortés, R. (1999) Synapse, 34, 68-76.
58. Castro, M.E.; Harrison, P.J.; Pazos, A. and Sharp, T. (2000) J. Neurochem., 75, 755-762.
59. Martinez, D.; Hwang, D.R.; Mawlawi, O.; Slifstein, M.; Kent, J.; Simpson, N.; Parsey, R.V.; Hashimoto, T.; Huang, Y.Y.; Shinn, A.; VanHeertum, R.; Abi-Dargham, A.; Caltabiano, S.; Malizia, A.; Cowley, H.; Mann, J.J. and Laruelle, M. (2001) Neuropsychopharmacology, 24, 209-229.
60. Rabiner, E.A.; Bhagwagar, Z.; Gunn, R.N.; Sargent, P.A.; Bench, C.J.; Cowen, P.J. and Grasby, P.M. (2001) Am. J. Psychiatry, 158, 2080-2082.
61. Haddjeri, N.; Blier, P. and de Montigny, C. (1998) J. Affect. Disord., 51, 255-266.
62. Middlemiss, D.N.; Neill, J. and Tricklebank, M.D. (1985) Br. J. Pharmacol., 85, 25.
63. Middlemiss, D.N. (1986) Eur. J. Pharmacol., 120, 51-56.
64. Lesch, K.P.; Poten, B.; Sohnle, K. and Schulte, H.M. (1990) Eur. J. Clin. Pharmacol., 39, 17-19.
65. Newman-Tancredi, A.; Chaput, C.; Gavaudan, S.; Verriele, L. and Milian, M.J. (1998) Neuropsychopharmacology, 18, 395-398.
66. Clifford, E.M.; Gartside, S.E.; Umbers, V.; Cowen, P.J.; Hajós, M. and Sharp, T. (1998) Br. J. Pharmacol., 124, 206-212.
67. Fornal, C.A.; Martin, F.J.; Mendlin, A.; Metzler, C.W.; Bjorvatn, B. and Jacobs, B.L. (1999) Eur. J. Pharmacol., 377, 187-191.
68. Bosker, F.J.; Donker, M.G.; Klompmakers, A.A.; Kurata, K. and Westenberg, H.G.M. (1994) Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 18, 765-778.
69. Dreshfield, L.J.; Wong, D.T.; Perry, K.W. and Engleman, E.A. (1996) Neurochem. Res., 21, 557-562.
70. Fornal, C.A.; Martin, F.J.; Metzler, C.W. and Jacobs, B.L. (1999) J. Pharmacol. Exp. Ther., 291, 220-228.
71. Miguez, J.M.; Paz-Valinas, L.; Miguez, I. and Aldegunde, M. (2002) Naunyn-Schmied. Arch. Pharmacol., 365, 378-387.
72. Rasmussen, K.; McCreary, A.C. and Shanks, E.A. (2004) Neurosci. Lett., 355, 14.
73. Guilloux, J.P.; Guiard, B.P.; Artigas, F.; Bourin, M.; Toth, M. and Gardier, A. (2004) Soc. Neurosci. Abstr. No 394.13
74. Dawson, L.A.; Nguyen, H.Q.; Smith, D.I. and Schechter, L.E. (2000) Br. J. Pharmacol., 130, 797-804.
75. Parks, C.L.; Robinson, P.S.; Sibille, E.; Shenk, T. and Toth, M. (1998) Proc. Natl. Acad. Sci. USA, 95, 10734-10739.
76. Tome, M.B.; Isaac, M.T.; Harte, R and Holland, C. (1997) Int. Clin. Psychopharmacol., 12, 81-89.
77. Bordet, R.; Thomas, P. and Dupuis, B. (1998) Am. J. Psychiatry, 155, 1346-1351.
78. Zanardi, R.; Franchini, L.; Gasperini, M.; Lucca, A.; Smeraldi, E. and Pérez, J. (1998) J. Clin. Psychopharmacol., 18, 441-446.
79. Berman, R.M.; Anand, A.; Cappiello, A.; Miller, H.L.; Hu, X.S.; Oren, D.A. and Charney, D.S. (1999) Biol. Psychiatry, 45, 1170-1177.
80. Shiah, I.S.; Yatham, L.N.; Srisurapanont, M.; Lam, R.W.; Tam, E.M. and Zis, A.P. (2000) J. Clin. Psychopharmacol., 20, 373-378.
81. Maes, M.; Vandoolaeghe, E. and Desnyder, R. (1996) J. Affect. Disord., 41, 201-210.
82. Moreno, F.A.; Gelenberg, A.J.; Bachar, K. and Delgado, P.L. (1997) J. Clin. Psychiatry, 58, 437-439.
83. Maes, M.; Libbrecht, L; van Hunsel, F.; Campens, D. and Meltzer, H.Y. (1999) J. Clin. Psychopharmacol., 19, 177-182.
84. Pérez, V.; Soler, J.; Puigdemont, D.; Alvarez, E.; Grup de Recerca en Trastorns Afectius and Artigas, F. (1999) Arch. Gen. Psychiatry, 56, 375-379.
85. Smeraldi, E.; Benedetti, F.; Barbini, B.; Campori, E. and Colombo, C. (1999) Neuropsychopharmacology, 20, 380-385.
86. Perry, E.B.; Berman, R.M.; Sanacora, G.; Anand, A.; Lynch-Colonese, K. and Charney, D.S. (2004) J. Clin. Psychiatry, 65, 238-243.
87. Richer, M.; Hen, R. and Blier, P. (2002) Eur. J. Pharmacol., 435, 195-203.